La ciclosporine topique: Quand et comment l'utiliser ?MILAZZO, Solange; DRIMBEA, Andrei; JANY, Benjamin et al.Pratiques en ophtalmologie. 2014, Vol 8, Num 76, pp 166-169, issn 2106-9735, 4 p.Article

Calcineurin inhibitors in oral medicineAL JOHANI, Khalid A; HEGARTY, Anne M; PORTER, Stephen R et al.Journal of the American Academy of Dermatology. 2009, Vol 61, Num 5, pp 829-840, issn 0190-9622, 12 p.Article

CiclosporinePAUL, C; GARAT, H.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 836-838, issn 0151-9638, 3 p.Article

Innovative Use of Topical Calcineurin InhibitorsLIN, Andrew N.Dermatologic clinics. 2010, Vol 28, Num 3, issn 0733-8635, 535-545, viii [12 p.]Article

Reduced Exposure to Calcineurin Inhibitors in Renal TransplantationEKBERG, Henrik; TEDESCO-SILVA, Helio; VANRENTERGHEM, Yves et al.The New England journal of medicine. 2007, Vol 357, Num 25, pp 2562-2575, issn 0028-4793, 14 p.Article

HCV resistance to cyclosporin A does not correlate with a resistance of the NSSA―cyclophilin A interaction to cyclophilin inhibitorsCHATTERJI, Udayan; LIM, Precious; GALLAY, Philippe A et al.Journal of hepatology. 2010, Vol 53, Num 1, pp 50-56, issn 0168-8278, 7 p.Article

Topical tacrolimus has a limited direct effect on ultraviolet B-irradiated keratinocytes: implications for its photocarcinogenic potentialLAN, C.-C. E; YU, H.-S; HUANG, S.-M et al.Clinical and experimental dermatology (Print). 2010, Vol 35, Num 2, pp 173-179, issn 0307-6938, 7 p.Article

Efficacy of Topical Calcineurin Inhibitors in Lichen PlanusSAMYCIA, Michael; LIN, Andrew N.Journal of cutaneous medicine and surgery. 2012, Vol 16, Num 4, pp 221-229, issn 1203-4754, 9 p.Article

Age-associated differences in the inhibition of mitochondrial permeability transition pore opening by cyclosporine ALIU, L; ZHU, J; BRINK, P. R et al.Acta anaesthesiologica scandinavica. 2011, Vol 55, Num 5, pp 622-630, issn 0001-5172, 9 p.Article

Cyclosporine for Ocular Inflammatory DiseasesKACMAZ, R. Oktay; KEMPEN, John H; LEVY-CLARKE, Grace A et al.Ophthalmology (Rochester, MN). 2010, Vol 117, Num 3, pp 576-584, issn 0161-6420, 9 p.Article

Lip hypertrophy secondary to cyclosporine treatment : a rare adverse effect and treatment considerationsBHATTACHARYYA, Indraneel; ISLAM, Mohammed N; YOON, Thomas Y. H et al.Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics. 2006, Vol 102, Num 4, pp 469-474, issn 1079-2104, 6 p.Article

Effects of tacrolimus on an organotypic raft-culture model mimicking oral mucosaRAUTAVA, J; PÖLLÄNEN, M; LAINE, M. A et al.Clinical and experimental dermatology (Print). 2012, Vol 37, Num 8, pp 897-903, issn 0307-6938, 7 p.Article

Compatibility of Tacrolimus Ointment with Corticosteroid Ointments of Varying PotenciesPAPPAS, Lisa; KISS, Alex; LEVITT, Jacob et al.Journal of cutaneous medicine and surgery. 2009, Vol 13, Num 3, pp 140-145, issn 1203-4754, 6 p.Article

Effect of Calcineurin Inhibitors on Posaconazole Blood Levels as Measured by the MVista Microbiological AssayZHUANG, David; SMEDEMA, Melinda; LEMONTE, Ann et al.Antimicrobial agents and chemotherapy. 2008, Vol 52, Num 2, pp 730-731, issn 0066-4804, 2 p.Article

Vasomotor Dysfunction in the Mesenteric Artery after Organ Culture with Cyclosporin AZHENG, Jian-Pu; XUEMEI ZHANG; HAO WANG et al.Basic & clinical pharmacology & toxicology (Print). 2013, Vol 113, Num 6, pp 370-376, issn 1742-7835, 7 p.Article

Mesures de prévention et de traitement en transplantation hépatique = Chronic renal dysfunction after liver transplantation : prevention and treatmentAUDIN-MAMLOUK, H; CHERMAK-CORVAISIER, F; PAGEAUX, G. P et al.Le Courrier de la transplantation. 2008, Vol 8, Num 1, pp 28-32, issn 1628-8319, 5 p.Article

Mécanismes moléculaires de l'activité des immunosuppresseurs actuels en transplantation : rôles du pharmacien : Traitements immunosuppresseurs en transplantation = Today in molecular mechanisms of immunosuppressive drugs actions: Roles of pharmacistHULIN, A.Annales pharmaceutiques françaises. 2008, Vol 66, Num 2, pp 102-114, issn 0003-4509, 13 p.Article

Histoire naturelle de la néphrotoxicité : les leçons tirées des maladies auto-immunes = Natural history ofnephrotoxicity : lessons learned from autoimmune diseasesISNARD-BAGNIS, C; TOSTIVINT, I; DERAY, G et al.Le Courrier de la transplantation. 2008, Vol 8, Num 1, pp 14-18, issn 1628-8319, 5 p.Article

Physiopathologie de la néphrotoxicité des inhibiteurs de la calcineurine = Pathophysiology ofcalcineurin inhibitors nephrotoxicityPALLET, N; ANGLICHEAU, D.Le Courrier de la transplantation. 2008, Vol 8, Num 1, pp 9-13, issn 1628-8319, 5 p.Article

Néphrotoxicité des inhibiteurs de la calcineurine : mesures de prévention et traitement en transplantation rénale = Prevention and treatment ofcalcineurin inhibitors-induced nephrotoxicity in kidney transplant patientsHAZZAN, M.Le Courrier de la transplantation. 2008, Vol 8, Num 1, pp 21-25, issn 1628-8319, 5 p.Article

Mesures de prévention et de traitement de la néphrotoxicité des anticalcineurines en transplantation cardiaque = Prevention and treatment of calcineurin inhibitors-induced nephrotoxicity in heart transplant patientsSEBBAG, L.Le Courrier de la transplantation. 2008, Vol 8, Num 1, pp 33-36, issn 1628-8319, 4 p.Article

Lettre d'information pour le traitement du psoriasis par la ciclosporine orale = Information letter on treatment of psoriasis with oral cyclosporineAnnales de dermatologie et de vénéréologie. 2011, Vol 138, Num 12, pp 863-864, issn 0151-9638, 2 p.Article

Long-Term Maintenance Therapy With Calcineurin Inhibitors: An UpdateCAMPISTOL, J. M.Transplantation proceedings. 2010, Vol 42, Num 9, issn 0041-1345, S21-S24, SUPConference Paper

The Role of Calcineurin Inhibitors in the Management of Lichen SclerosusYESUDIAN, Paul D.American journal of clinical dermatology. 2009, Vol 10, Num 5, pp 313-318, issn 1175-0561, 6 p.Article

Calcineurin Inhibitor Sparing in Renal TransplantationEKBERG, Henrik.Transplantation. 2008, Vol 86, Num 6, pp 761-767, issn 0041-1337, 7 p.Article